Solgar company review

Company Overview of Solgar Inc.

Company Overview

Solgar Inc. produces and supplies nutritional supplements. The company offers products in the categories of acai, acidophilus/probiotics, amino acids, antioxidants, blood sugar support products, bone and joint supports, calcium, brain and cardiovascular health products, carotenoids, and children's health. It also provides coenzyme Q-10, digestive health supplements, energy and stamina products, essential fatty acids, eye health products, fish oils, foods, glucosamine and chondroitin, gold specifics, herbs, and immune and liver support products; and A, B, C, D, E, and K vitamins. In addition, the company offers minerals, multiples, omegas, platinum editions, proteins, red yeast rice, resverat.

Solgar Inc. produces and supplies nutritional supplements. The company offers products in the categories of acai, acidophilus/probiotics, amino acids, antioxidants, blood sugar support products, bone and joint supports, calcium, brain and cardiovascular health products, carotenoids, and children's health. It also provides coenzyme Q-10, digestive health supplements, energy and stamina products, essential fatty acids, eye health products, fish oils, foods, glucosamine and chondroitin, gold specifics, herbs, and immune and liver support products; and A, B, C, D, E, and K vitamins. In addition, the company offers minerals, multiples, omegas, platinum editions, proteins, red yeast rice, resveratrol, sleep support and weight management products, and women's and men's health products, as well as products for skin, hair, and nails health. It markets and sells its products through health food retailers worldwide. The company was founded in 1947 and is based in Leonia, New Jersey. It has operations in Andorra, Aruba, Bahrain, Belgium, Bermuda, Bulgaria, Colombia, Croatia, Curacao, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Israel, Italy, Korea, Kuwait, Malta, the Netherlands, Holland, New Zealand, Norway, Sweden, Panama, Peru, the Philippines, Poland, Portugal, Romania, the Russian Federation, Singapore, South Africa, Spain, Switzerland, Turkey, Ukraine, the United Arab Emirates, the United Kingdom, and Venezuela; and Barbados and Trinidad, West Indies. Solgar Inc. operates as a subsidiary of NBTY, Inc.

500 Willow Tree Road

Leonia, NJ 07605

Key Executives for Solgar Inc.

Vice President of Product Development

Director of Research and Development

Vice President of Marketing and General Manager

Senior Vice President of Global Sales & Marketing

Compensation as of Fiscal Year 2016.

Solgar Inc. Key Developments

Solgar, Inc. Announces Recall of ABC Dophilus Powder

Solgar, Inc. is voluntarily recalling ABC Dophilus(R) Powder. The recall was initiated, out of an abundance of caution, because the product was found to contain Rhizopus oryzae, which may cause Mucormycosis. This is a rare infection that may cause health problems to consumers, particularly pre-mature infants/infants, children, and those with weakened immune systems. Although, it may also occur (rarely) in people who are otherwise healthy. Susceptible consumers should consult with their physician or health care provider if they have used this product. The company is notifying consumers and customers not to consume this product. This product was distributed to: AL, AR, AZ, CA, CT, CO, FL, IA, IL, IN, MI, ME, MO, MA, NC, NE, NY, NJ, NV, OH, OK, PA, PR, UT, TN, TX, VT, KY, WI, WA, UK and Israel through pharmacy, retail stores, wholesale, internet, etc. Description: Solgar ABC Dophilus(R) Powder NET Wt. 1.75 oz (50 g). UPC Code: 0 33984 00010 0. Label: Solgar. Lot# 074024-01R1, 074024-01, 074024-02. Expiration Date 7/31/15. Testing conducted by the Center for Disease Control revealed the presence of Rhizopus oryzae in 1.75 oz (50 g) containers of Solgar ABC Dophilus Powder. The distribution of the product has been suspended while FDA and the company continue to investigate the source of the problem. Risk factors for developing Mucormycosis include: uncontrolled diabetes; cancer; organ transplant; neutropenia (low white blood cells); skin trauma (cuts, scrapes, punctures, or burns). Susceptible consumers should consult with their physician or health care provider. Consumers who have purchased Solgar ABC Dophilus(R) Powder are urged not to consume the product and should return it to the place of purchase for a full refund.

Similar Private Companies By Industry

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Solgar Inc. please visit www.solgar.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Information Missing - Please enter your information in the following field(s):